A murder trial in the U.S. is focusing attention on the complex relationship between psychiatric medications and severe behavioral changes. Lindsay Clancy, a former nurse from Massachusetts, stands accused of killing her three young children in January 2023. While the defense does not dispute that Clancy caused the deaths, it centers its case on the argument that she was not guilty by reason of insanity, potentially due to postpartum psychosis and the effects of prescribed medications.

Clancy was prescribed sertraline, an SSRI antidepressant, three months after the birth of her youngest son to help with anxiety and insomnia. According to reports, she experienced significant side effects, including 48 hours without sleep and racing thoughts, after her dose was increased. Over the following four months, she was prescribed a total of 13 different psychiatric medications, including antidepressants, antipsychotics, benzodiazepines, and sleeping medication.

During the trial, Clancy's defense attorney sought to introduce the concept of 'involuntary intoxication,' arguing that the prescribed medications and withdrawal effects could have contributed to her mental state. Although the judge did not allow this specific argument, the role of the medications remains a central theme. The defense has blamed the tragedy in part on "the damn medicine and the lousy medical care that she got."

Clancy herself has stated that she heard a commanding voice instructing her to kill her children and then herself, describing a dissociative, dream-like state where she lost control. A forensic psychiatrist testified that Clancy was "clearly psychotic" when the killings occurred and not in control of her actions, comparing her to a "puppet."

This case has drawn parallels to other instances where psychiatric medication has been implicated. In 1999, Marilyn Lemak, a mother with no prior history of violence, killed her three children and attempted suicide. She had been prescribed sertraline and later the tranquilizer lorazepam, with her mental state deteriorating as her dosage increased. While prosecutors portrayed Lemak as vengeful, her lawyers argued for insanity. A jury found her guilty of murder, and she was sentenced to life in prison. Her legal team is now pursuing a clemency petition, arguing that the role of sertraline in her mental state was not adequately considered during her trial.

Experts, such as psychiatrist Professor David Healy, suggest that certain psychiatric drugs can induce states in individuals, even those with no prior mental illness, leading them to act completely out of character. A systematic review of clinical trials, published in the Journal of the Royal Society of Medicine by Professor Peter Gotzsche, indicated that antidepressants can double the occurrence of events leading to suicide and violence in healthy adults. These findings suggest that for a minority of individuals, these medications can pose significant risks.

The prescribing information for medications like sertraline acknowledges potential side effects, including suicidal thoughts, psychotic disorders, hallucinations, aggression, and paranoia, affecting up to one in 100 people. Clancy reportedly expressed concerns about the medications, telling prescribers they made her feel "spacey," numb, and disconnected from her body. Her husband also noted a significant worsening of her condition after starting medication and inquired about stopping it.

Clinicians at a specialist perinatal program noted that Clancy's symptoms appeared to be "more pharmacologically induced than purely depressive" and were concerned about her being overmedicated. While she was advised to stop certain medications, the prescribing information for some drugs warns of discontinuation syndromes, and guidelines note that stopping antidepressants can lead to anxiety, insomnia, agitation, and suicidal thoughts. The prosecution has contended that medication could not have been a factor, citing relatively low drug levels at the time of the killings.

The case raises critical questions about the potential impact of starting, stopping, and switching doses of psychiatric medications, as well as withdrawal effects, on a person's mental state and behavior. The author, who experienced a severe adverse drug reaction to psychiatric medications years ago, founded Antidepressant Risks CIC to support individuals affected by psychiatric drugs and bereaved families, regularly hearing accounts of sudden suicidality and intrusive thoughts linked to medication changes.